Qube Research & Technologies (QRT)
VCNX

Qube Research & Technologies (QRT)’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-217
Closed -$81K – 2283
2020
Q3 		$81K Buy
+217
New +$237K ﹤0.01% 1509

Other funds holding VCNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VCNX Position: Q4 2020 in Review

Qube Research & Technologies (QRT) sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2020, closing a stake of 217 shares — an estimated $81K sold.

Qube Research & Technologies (QRT) first reported a position in VCNX in Q3 2020 and held it in 1 quarter. The position peaked at $81K in Q3 2020. 18 funds tracked by Wall St. Rank hold VCNX as of Q4 2020.

  • Qube Research & Technologies (QRT) reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 217 Vaccinex, Inc. Common Stock shares in Q4 2020, an estimated $81K.
  • Qube Research & Technologies (QRT) first reported a position in Vaccinex, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Vaccinex, Inc. Common Stock position peaked at $81K in Q3 2020.
  • 18 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2020, filed 16 Feb 2021.